Navigation Links
Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
Date:8/1/2013

y 47 territories.
  • On July 15, 2013, the Company and Swedish Orphan Biovitrum AB (STO: SOBI) announced a long-term collaboration for the development, supply and commercialization of XIAPEX®  (collagenase clostridium histolyticum), a novel, first-in-class biologic for the treatment of Dupuytren's contracture, in 71 Eurasian and African countries.  In addition, work is on-going to file for approval of XIAPEX for the treatment of Peyronie's disease in the EU. Under the terms of the agreement, Auxilium expects to receive significant tiered double-digit royalties based on sales of XIAPEX in Sobi's territories, which will also cover payment for product supply.  Additionally, Auxilium could receive up to $40 million in potential sales milestone payments from Sobi.
  • In the second quarter of 2013, Auxilium completed enrollment for a 725 patient study with XIAFLEX for the concurrent treatment of multiple palpable cords that, if successful, could allow the Company to seek FDA approval and expansion of the Dupuytren's label.
    Top-line data from this study is now expected by the end of 2013. 
  • On April 29, 2013, Auxilium announced that it had completed the acquisition of Actient Holdings LLC ("Actient"), a private urology specialty therapeutics company, for $585 million in upfront cash plus certain contingent consideration and warrants to purchase Auxilium common stock.
  • Second Quarter 2013 Financial Details 
    Total revenues for the three months ended June 30, 2013 were $100.5 million, an increase of 29% over the $78.2 million recorded in the second quarter of 2012.  This increase in net revenues was due to increases in U.S. sales of XIAFLEX and the addition of the Actient products, which are included in Auxilium results since the closing of the transaction on April 26, 2013.  For the second quarter of 2013, U.S. XIAFLEX net revenues increased by 26% and U.S. Testim net revenues decrea
    '/>"/>

    SOURCE Auxilium Pharmaceuticals, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
    2. Auxilium Pharmaceuticals to Announce First Quarter 2012 Results and Conduct Conference Call on Thursday, May 10, 2012
    3. Auxilium Pharmaceuticals, Inc. to Present At The BofAML 2012 Health Care Conference
    4. Auxilium Pharmaceuticals, Inc. and FCB I LLC Announce the Issuance of Composition of Matter Patent Covering Testim
    5. Auxilium Pharmaceuticals, Inc. Raises Revenue Guidance And Reduces Net Loss Guidance For 2012
    6. Auxilium Pharmaceuticals, Inc. to Present at the Goldman Sachs Global Healthcare Conference 2012
    7. Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2012 Financial Results
    8. Auxilium Pharmaceuticals to Announce Third Quarter 2012 Results and Conduct Conference Call on Wednesday, November 7, 2012
    9. Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
    10. Auxilium Pharmaceuticals, Inc. Announces Offering of Convertible Senior Notes Due 2018
    11. Auxilium Pharmaceuticals, Inc. Announces Pricing of $325.0 Million of 1.50% Convertible Senior Notes Due 2018
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:6/2/2015)... their reach nationally by providing customers with on-site 17025 accredited pipette calibrations. ... ... ... ... Photo - http://photos.prnewswire.com/prnh/20150601/219758 As an industry-leading ...
    (Date:6/2/2015)... , June 2, 2015  Ashion™ Advanced ... rapidly evolving genomic medicine industry, announced today ... service using Syapse Precision Medicine Platform. AIM ... (PMCs) with partner regional healthcare systems, providing ... genomic interpretation, education, and operational support. AIM ...
    (Date:6/2/2015)... Mass., June 2, 2015 Today, Accuratus ... Capital Partners (Ampersand), announced the acquisition of the ... BioPharma Inc. (Array).  Accuratus was formed in July ... MN acquired Microtest Labs of Agawam, ... microbial testing services to the medical device and ...
    Breaking Medicine Technology:Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 2Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 3Integrated Service Solutions, Inc. Announces Nationwide Expansion for On-site Pipette Calibrations 4Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 2Ashion Advanced Individual Medicine Chooses Syapse to Enable Genomics-Based Cancer Care in the Community 3Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 2Accuratus Lab Services Expands Capabilities with Acquisition of CMC Operation of Array BioPharma 3
    ... 2012 Stereotaxis, Inc. (NASDAQ:   STXS) today ... European market the V-Sono™ intracardiac echocardiography manipulator module ... Designed to manipulate accessory devices such as variable ... Vdrive™ platform combines magnetic navigation with the Odyssey™ ...
    ... (NASDAQ: KERX ), a biopharmaceutical company focused ... pharmaceutical products for the treatment of renal disease (the ... ended March 31, 2012. At March 31, ... and investment securities of $31.0 million, as compared to ...
    Cached Medicine Technology:Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System 2Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System 3Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 2Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 3Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results 4
    (Date:6/2/2015)... 02, 2015 The Horizon Blue Cross ... that its Walking and Wellness Challenge, held this past ... has raised another $3,000 for the Boys & Girls ... challenge, recording 32,000 steps on her fitbit during her ... & Golf Club in Galloway Township. , When ...
    (Date:6/2/2015)... (PRWEB) June 02, 2015 Did you wish ... what to get him, his family isn’t asking for presents, ... the team walking in Saturday’s Cure HHT DC Walk. , ... disease that causes malformed blood vessels leading to sudden and ... to appear when Ryder was 3 years old in the ...
    (Date:6/2/2015)... Bradenton, MI (PRWEB) June 02, 2015 ... a new website to promote its handmade gourmet pizzas ... But even though the website is new, the recipes ... customers since 1995. The main feature of the site ... includes appetizing pictures and descriptions of all the items. ...
    (Date:6/2/2015)... (PRWEB) June 02, 2015 MAP Health ... and revenue cycle management for addiction treatment facilities, announced ... Vice President of Marketing. Mr. Smith will be responsible ... the awareness and visibility of MAP’s core message, products ... was the Marketing Manager at Cottonwood Financial in Irving, ...
    (Date:6/2/2015)... 2015 ANT Wireless, proven innovator ... Pole Engineering’s (NPE) announcement of three next generation ... WASP-PoE-2 and WASP-PoE-3. WASP is a standalone ANT ... bridge solution that allows data collected from low-power ... Ethernet networks. , The new generation ...
    Breaking Medicine News(10 mins):Health News:LPGA’s Natalie Gulbis Raises an Additional $3,000 for the Boys & Girls Club of Atlantic City Through Horizon BCBSNJ’s Walking and Wellness Challenge 2Health News:Six-Year-Old Walks to Bring Awareness to Genetic Disease 2Health News:Erbelli’s of Bradenton Launches New Mobile-Friendly Website 2Health News:Jared Smith Joins MAP Health Management, LLC, as Vice President of Marketing 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 2Health News:ANT Technology Incorporated in Second Generation WASP Bridge Products 3
    ... FRANCISCO, Jan. 9 Blue Shield of California ... to manage the company,s rapid growth and pursue new strategic ... to spearhead the company,s success, Blue Shield chairman and CEO ... , Paul ...
    ... in 42 states have been sickened , , FRIDAY, Jan. 9 ... has sickened almost 400 Americans in 42 states remains unknown, ... expected. , The strain of salmonella has been identified as ... than 2,500 types of salmonella bacteria in the United States. ...
    ... class of the Henry Ford Health,System,s nursing recruitment program for ... In partnership with Oakland University , Henry Ford developed ... address the nursing shortage.,The U.S. Bureau of Labor Statistics estimates ... needed by 2012. , Oakland ...
    ... New Deal Means an Additional 480 positionsCAMP HILL, ... been selected by The Centers for Medicare and ... claims from hospitals and other institutional providers, physicians ... This contract also includes the processing of Home ...
    ... -- A unique discovery in a Florida State University ... with the potential to one day help scientists learn ... tissue where they are forming. , Jamila Horabin, associate ... has received a four-year, $1.2 million grant from the ...
    ... gene have disease relapse often within 5 years of apparent ... they have identified a rare subtype of a childhood leukemia ... the subtype of acute lymphoblastic leukemia (ALL) have a BCR-ABL1 ... children recently diagnosed with ALL, those with this gene tended ...
    Cached Medicine News:Health News:Paul Markovich Named Chief Operating Officer of Blue Shield of California 2Health News:Paul Markovich Named Chief Operating Officer of Blue Shield of California 3Health News:Officials Still Seek Source of Salmonella Outbreak 2Health News:Highmark Medicare Services Awarded New Contract from Centers for Medicare & Medicaid Services 2Health News:Highmark Medicare Services Awarded New Contract from Centers for Medicare & Medicaid Services 3Health News:Researcher wins $1.2 million grant for gene regulation work 2Health News:Childhood Leukemia Subtype Resists Treatment 2
    The Closer vascular closure device is a suture mediated closure system. It has a sheath-like profile and easy positioning. It has an innovative design which involves the needles outside the artery an...
    Femoral selective diagnostic catheter.The material used is polyurethane (DUCOR). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
    These are coronary angiographic catheters used for selective coronary bypass angiography. The catheters curve configuration is ideally suited to select the internal mammary artery....
    Femoral selective catheter. Catheter material used is polyurethane (DUCOR). Guidewire campatibility is 0.038". Packaging 5/Box....
    Medicine Products: